Hepatocellular carcinoma biomarkers, an imminent need

World J Gastrointest Oncol. 2021 Nov 15;13(11):1847-1849. doi: 10.4251/wjgo.v13.i11.1847.

Abstract

Hepatocellular carcinoma (HCC) is the most common malignant neoplasm of the liver and one of the deadliest cancers worldwide. The identification of novel, highly specific and more sensitive biomarkers for HCC is crucial because existing ones are deficient and non-confirmatory without histological biopsy or imaging techniques.

Keywords: Biomarker; Blood; Feces; Gut microbiota; Hepatocellular carcinoma; Urine.